# Continuous Diffusion of Oxygen Treatment for Incision Wounds

> **NCT04307355** · NA · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 23 (actual)

## Conditions studied

- Surgical Wound
- Breast Surgery
- Mammoplasty
- Incision Wound

## Interventions

- **DEVICE:** Transcu O2®
- **OTHER:** Tegaderm
- **OTHER:** Silagen

## Key facts

- **NCT ID:** NCT04307355
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2023-08-28
- **Final completion:** 2023-08-28
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04307355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04307355, "Continuous Diffusion of Oxygen Treatment for Incision Wounds". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04307355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
